Merckle may have to sell Ratiopharm -sources


FRANKFURT, Dec 27 (Reuters) - German tycoon Adolf Merckle might have to sell his generic drugs maker Ratiopharm as part of a broader financial rescue package agreed with creditor banks, two sources close to the matter told Reuters on Saturday. It would boil down to a sale of Ratiopharm, one of the sources said. German newspaper Suedwest Presse had reported on its website on Friday that a sale of Ratiopharm was likely and was probably unavoidable, citing the head of Ratiopharm's work ...

Premium Content (PAID Subscription Required)

"Merckle may have to sell Ratiopharm -sources" is part of the paid WardsAuto Premium content. You must log in with Premium credentials in order to access this article. Premium paid subscribers also gain access to:

  All of WardsAuto's reliable, in-depth industry reporting and analysis
  Hundreds of downloadable data tables including:
  •   Global sales and production data by country
  •   U.S. model-line inventory data
  •   Engine and equipment installation rates
  •   WardsAuto's North America Plant by Platform forecast
  •   Product Cycle chart
  •   Interrelationships among major OEMs
  •   Medium- and heavy-duty truck volumes
   •  Historical data and much more!

For pricing and subscription information please contact
Lisa Williamson by email: or phone: (248) 799-2642

Current subscribers, please login or CLICK for support information.

Already registered? here.

Feb 10, 2017

Volvo V60 Polestar 2.0L Turbo/Supercharged DOHC 4-cyl. -- 2017 Award Acceptance

Stefan Hermelin, general manager-Monitoring & Concept Center, accepts Volvo Cars' award at the 2017 Wards 10 Best Engines ceremony....More


Follow Us

Sponsored Introduction Continue on to (or wait seconds) ×